Analysis-Bulls beat a path to China stock shop but foreigners dare not go in
By Samuel Shen and Dhara Ranasinghe SHANGHAI/LONDON (Reuters) - Emboldened by China's latest measures and pledges to fix the weakest parts of its ...
Stay updated with breaking news from Ping An. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Samuel Shen and Dhara Ranasinghe SHANGHAI/LONDON (Reuters) - Emboldened by China's latest measures and pledges to fix the weakest parts of its ...
Share prices have rebounded from multi-year lows in February on signs of more official support. The benchmark Shanghai index has climbed more than 3% since reports of the property rescue surfaced on Thursday, taking its gains to a fifth in 3-1/2 months, though the rally stalled on Tuesday as investors awaited more details on how the funding would work. Hong Kong-listed Chinese shares are up nearly 38%
China gave the green light to Eli Lilly & Co.'s blockbuster drug tirzepatide for use in treating diabetes, a move that will intensify the drugmaker's rivalry with Novo Nordisk A/S over weight-loss drugs in the world's second-largest market.
Operator: Ladies and gentlemen, thank you for standing by, and welcome to OneConnect's First Quarter 2024 Earnings Call. Please note this event is being recorded.
As China's economy shows signs of revitalisation, domestic investors eagerly embrace the nation's strategic moves.